SEARCH

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    US tariff heat: Fitch says Indian firms face limited direct hit; pharma sector seen at risk if duties widen

    2 weeks ago

    Fitch Ratings cautions that while Indian corporates have limited direct exposure to current US tariffs, sectors like pharmaceuticals could face risks if further measures are imposed. The US has levied a 25% tariff on Indian goods since August 7, 2025, with another 25% due on August 27, due to India's Russian oil imports.
    Click here to Read more
    Prev Article
    With Pak pulling out over security concerns, Hockey Asia Cup 2025 to begin in India
    Next Article
    Rare earth supply crunch: China’s export ban impacts EV industry, India seeks new partners

    Related Business Updates:

    Comments (0)

      Leave a Comment